CRL · 8-K · 20260805PR000115
NHP Regulatory Investigation Resolution
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 53 · Surprise 60 · In source text
The company said U.S. government investigations into the non-human-primate supply chain were resolved during fiscal 2025. Following resolution, certain previously written-down NHPs were utilized, partially reversing a $27 million inventory charge recorded in fiscal 2024. The disclosure identifies USDA and FDA regulations and changes in law as continuing regulatory considerations, but reports no new investigation or penalty in the quarter.
Key facts
- The Company reduced a previous $27 million inventory charge associated with an NHP supply matter as part of 'Other, net' adjustments described in guidance footnote (5). source
- DSA reported lower third‑party legal and advisory costs in Q2 2026 related to concluded U.S. government investigations into the NHP supply chain. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | positive | realized | +2.7% | The Company reduced a previous $27 million inventory charge associated with an NHP supply matter as part of 'Other, net' adjustments… |